The Covid Drug Wars That Pitted Doctor vs. Doctor
How much freedom should front-line clinicians have in treating Covid-19 patients with unproven drugs? The question opened up a civil war in some hospitals. More
How much freedom should front-line clinicians have in treating Covid-19 patients with unproven drugs? The question opened up a civil war in some hospitals. More
Conversations about death from Covid-19 revolve around patient characteristics. But hospitals matter, too. More
A recent study in JAMA finds that nearly half of older adults are still screened for certain cancers above the recommended age. More
While everyone is focused on the current pandemic, how can we take actions now to reduce the threat of antibiotic resistance? More
As the world races to find a vaccine and a treatment for COVID-19, there is seemingly no antidote in sight for the burgeoning outbreak of coronavirus conspiracy theories, hoaxes, anti-mask myths and sham cures. More
In my cancer care so far, shared decision-making between doctor and patient is only half-working. More
Culturally sensitive communication within a trusted patient-physician relationship supplemented by pharmacists, and language tailored to specific clinical situations may support deprescribing in primary care for patients with dementia and MCC. More
Today’s news about a “breakthrough” test is certainly not the first we’ve heard like that about a possible Alzheimer’s test. More
How does one weigh patient safety against cost, especially when dealing with critically ill patients, for whom mistakes can cost lives? More
The label on a pill bottle lists the drug’s active and inactive ingredients, but new research concludes some “inactive” ingredients aren’t so inactive. More
Mental health apps are rarely evidence-based, according to a new study published in JNCN in Advance. More
Orthodontia is supposed to prevent a host of ills, from cavities to jaw pain. But some experts have found the evidence to be lacking. More
There's cause for optimism, but the race still has miles to go. More
Do the potential benefits of thrombolytic drugs for acute stroke outweigh the potential harms? In a guest blog, Drs W. Ken Milne and Daniel Fatovich examine this issue in light of new evidence. More
The American Academy of Family Physicians and National Alliance of Healthcare Purchaser Coalitions look to scale a care model that aims to shift away from fee-for-service reimbursement. More
The continuing costs of the pandemic combined with the impending financial crisis will inevitably mean having to do more with less. More
With only limited evidence of effectiveness, the drug should be put to a large clinical trial. More
Members of the Lown Institute Working Group on Medication Overload gave a webinar presentation last week, which is available to watch now! More
Unlike earlier in the year, most hospitals are not proactively canceling elective surgeries, even in some places seeing spikes in coronavirus patients. More
Proposed changes to lung cancer screening guidelines would could lead to more Black patients and women eligible for potentially life-saving scans. More